Derivative Instruments |
9 Months Ended |
|---|---|
Jun. 27, 2026 | |
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
| Derivative Instruments | Derivative Instruments During fiscal year 2024, the Company entered into a development and supply agreement and warrant agreements with a supplier, which entitle the Company to purchase a fixed number of shares of the supplier upon satisfaction of certain development and production-based milestones set forth therein (the “2024 Warrants”). The 2024 Warrants vested and are exercisable at a specified price per share until May 2044. The 2024 Warrants are accounted for as a derivative under ASC Topic 815, Derivatives and Hedging, as a result of certain net settlement provisions in the 2024 Warrants. The Company reports the 2024 Warrants at their fair values within “other assets” in its condensed consolidated balance sheets and changes in the fair value of the Warrants are recognized in “other income, net” on its condensed consolidated statements of operations. For the 2024 Warrants, the day-one value attributable to the other side of the warrants is reported within “other liabilities” in the Company’s condensed consolidated balance sheets and is amortized over the life of the applicable development and production milestones set forth in the development and supply agreement. The fair value of the 2024 Warrants recognized within “” on the Company’s condensed consolidated balance sheets at June 27, 2026 is $35.2 million. The Company recorded a fair value adjustment of $18.5 million to “other income, net” on the Company’s condensed consolidated statements of operations for the three and nine months ended June 27, 2026
|